Dr. Fred B. Rosenberg

Gastroenterology
Lake Shore Gastroenterology
20 Tower Ct Ste C, 
Gurnee, IL 
Accepting New Patients
Lake Shore Gastroenterology
20 Tower Ct Ste C, 
Gurnee, IL 

Overview

Fred Rosenberg is a Gastroenterologist practicing medicine in Gurnee, Illinois.

His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, Diarrhea, Gastrectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials. Dr. Rosenberg is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in IL

Languages Spoken

English
Italian
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Lake Shore Gastroenterology
20 Tower Ct Ste C, Gurnee, IL 60031
Other Locations
Lake Shore Gastroenterology
806 Central Ave Ste 202, Highland Park, IL 60035

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

2 Total Publications

Challenges Facing Independent Integrated Gastroenterology 2017.
Challenges Facing Independent Integrated Gastroenterology 2017.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 19, 2017
Similar Doctors
Expertise in
17
conditions
Dr. John E. Pandolfino
Gastroenterology
Expertise in
17
conditions
Dr. John E. Pandolfino
Gastroenterology
Referral may be required
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (37.0 miles away)
312-695-5620
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Pandolfino is a Gastroenterologist practicing medicine in Chicago, Illinois. Dr. Pandolfino is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Achalasia, Gastroesophageal Reflux Disease (GERD), Swallowing Difficulty, Endoscopy, and Colonoscopy. Dr. Pandolfino is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).

Expertise in
18
conditions
Dr. Peter J. Kahrilas
Gastroenterology
Expertise in
18
conditions
Dr. Peter J. Kahrilas
Gastroenterology
Referral may be required
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (37.0 miles away)
312-695-5620
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Peter Kahrilas is a Gastroenterologist practicing medicine in Chicago, Illinois. Dr. Kahrilas is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Achalasia, Gastroesophageal Reflux Disease (GERD), Heartburn, Endoscopy, and Gastrectomy. Dr. Kahrilas is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).

Expertise in
11
conditions
Dr. Nirmala P. Gonsalves
Gastroenterology
Expertise in
11
conditions
Dr. Nirmala P. Gonsalves
Gastroenterology
Referral may be required
Before you request
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (37.0 miles away)
312-695-5620
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nirmala Gonsalves is a Gastroenterologist practicing medicine in Chicago, Illinois. Dr. Gonsalves is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Esophagitis, Eosinophilic Esophagitis, Gastritis, Viral Gastroenteritis, and Endoscopy. Dr. Gonsalves is board certified in American Board Of Internal Medicine - Gastroenterology (Certified). Dr. Gonsalves is currently accepting new patients.

Frequently Asked Questions about Dr. Fred B. Rosenberg

How do I make an appointment with Dr. Fred B. Rosenberg?

You can book an appointment with Dr. Fred B. Rosenberg by calling their office at 847-244-2960. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Fred B. Rosenberg a top-rated expert for Gastroesophageal Reflux Disease (GERD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Fred B. Rosenberg is classified as an Experienced expert for Gastroesophageal Reflux Disease (GERD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Fred B. Rosenberg specialize in?

While Dr. Fred B. Rosenberg is a Gastroenterology, they have specific expertise in Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, and Diarrhea. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Fred B. Rosenberg participate in research or clinical trials?

Yes. Dr. Fred B. Rosenberg has published 2 articles and abstracts on conditions like Gastroesophageal Reflux Disease (GERD). You can view a list of Dr. Fred B. Rosenberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Fred B. Rosenberg accept my insurance?

Dr. Fred B. Rosenberg accepts most major insurance plans, including Health Care Services Corporation and Humana. We recommend calling the office directly at 847-244-2960 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenberg's expertise for a condition
ConditionClose
        View All 46 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile